Status:
COMPLETED
Clinical Comparative Analysis of Bretschneider and St. Thomas Cardioplegia Solution in Case of Mitral Valve Repair Via Anterolateral Right Thoracotomy
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Mitral Valve Reconstruction
Eligibility:
All Genders
Brief Summary
Mitral valve reconstruction via minimal invasive antero- lateral thoracotomy is done in cardioplegia with a cardioplegic solution, either HTK-Bretschneider (Custidiol®) (a crystalloid intracellular so...
Eligibility Criteria
Inclusion
- Mitral valve reconstruction via minimal invasive antero- lateral thoracotomy done in cardioplegia with a cardioplegic solution, either HTK-Bretschneider (Custidiol®) (a crystalloid intracellular solution) or St. Thomas (a crystalloid extracellular solution).
Exclusion
- Mitral valve reconstruction via minimal invasive antero- lateral thoracotomy done in cardioplegia with cardioplegic Solutions other than HTK-Bretschneider (Custidiol®) (a crystalloid intracellular solution) or St. Thomas (a crystalloid extracellular solution).
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03818113
Start Date
April 1 2019
End Date
August 30 2019
Last Update
November 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Herzchirurgie, Universitätsspital Basel
Basel, Switzerland, 4031